Evidence map›Paper›PMID 42193946›Full record

ReviewCells2026

The Interplay Between Antioxidant and Chaperone Functions of α-Crystallin.

Krishna Sharma, Puttur Santhoshkumar, Tenzin Tender

Abstract readReview
In one paragraph

Review in Cells, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Krishna SharmaDepartment of Ophthalmology, School of Medicine, University of Missouri-Columbia, Columbia, MO 65212, USA.
Puttur SanthoshkumarDepartment of Ophthalmology, School of Medicine, University of Missouri-Columbia, Columbia, MO 65212, USA.ORCID 0000-0002-6897-7278
Tenzin TenderDepartment of Ophthalmology, School of Medicine, University of Missouri-Columbia, Columbia, MO 65212, USA.

Funding

Metastable Crystallins: Structure and StabilizationR01EY023219 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI KRISHNA K SHARMA · 2013 to 2026
$5.9M
NIH HHS R01 EY023219
6 · The paper itself

Abstract

α-Crystallin, the predominant protein of the eye lens, possesses molecular chaperone activity and antioxidative properties, both of which are essential for maintaining lens transparency. Its chaperone function prevents the formation of light-scattering protein aggregates, while its antioxidative activity mitigates oxidative stress through both direct and indirect mechanisms. However, with aging, α-crystallin undergoes cumulative post-translational modifications and oxidative damage, leading to protein crosslinking and a decline in chaperone efficacy. Notably, α-crystallin exhibits free radical-scavenging activity comparable to that of serum albumin, a well-characterized antioxidant protein. In addition, its ability to bind redox-active metal ions and convert them into redox-inactive forms significantly reduces reactive oxygen species (ROS) generation in vivo. α-Crystallin also interacts with key proteins and signaling pathways involved in oxidative stress responses, further enhancing its multifunctional protective role. This review summarizes current evidence on the antioxidative properties of α-crystallin and their relationship to its chaperone function, highlighting its importance in lens homeostasis and age-related cataract formation.

Indexed as

alpha-CrystallinsAntioxidantsMolecular ChaperonesAnimalsCataractHumansLens, CrystallineOxidation-ReductionOxidative StressReactive Oxygen Speciesalpha-CrystallinsAntioxidantsMolecular ChaperonesReactive Oxygen Speciescataractchaperonecrystallinlensoxidation

Identifiers

PMID42193946
PMCPMC13204566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.